Member Info for 1pencil

Lots of things could happen from here on in, some wild cards below;

- Sustained Director/Chair share buying

- Kelso Raise even more dosh and go all in

- Sparta show their hand with Rule 8, continue to add

- Unknown entity (possibly Apollo) pop up on Rule 8 (now that would make it rocket..)

Seeing Baldertons holding not budging despite huge drops felt reassuring, out of all of the funds I have followed Balderton is way, way out in front arguably the best..

Purely from an embarrassment perspective, I think an MBO perhaps with Apollo/QIA backing is possibly. The amount of management/board time this circus consumes must be mind boggling - literally hundreds of thousands in fees and wasted corporate time which could be better spent elsewhere imo.

Going private has to be so tempting with such cost savings, brokers fees, stepping up to full listing and so on not to mention bad publicity which encircles the company and staff.

Tide is going out..lets see who is wearing what..bring on the 8's..

Balderton Capital (UK) LLP

Long

96,947,470 - 7.46%

--------------------------
Tuesday 24 May, 2022

96,947,470 - 7.94%

Nice find davey, hadn't realised that, things starting to look a bit more positive.

Lets see how Kelso respond, their AGM is due in April for fund raise approval - no doubt we will have some commentary (via media or otherwise) from both Sparta and Kelso.

BlackRock, Inc.

Long

16,110,551 - 1.23%

Short

23,182 - 0.00%

As a reference point The Vanguard Group, Inc. notified the following last time around Thursday 16 June, 2022

30,922,315 - 2.48%

first up of general interest;

The Vanguard Group, Inc.

Long position

34,023,301 2.62%

Hong Kong, Shanghai & Florham Park, NJ - Tuesday, April 18, 2023: HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces that its New Drug Application ("NDA") for fruquintinib in combination with paclitaxel for the treatment of second-line advanced gastric or gastroesophageal junction adenocarcinoma in China has been accepted for review by the China National Medical Products Administration ("NMPA").

https://www.lse.co.uk/rns/HCM/nda-acceptance-in-china-for-fruquintinib-f82xcz5yfyhylfn.html

It's not a bid, at least not yet anyway:

"highly preliminary and non-binding indicative proposal"

This time around it needs to have legs otherwise media will have a field day for crying wolf.

The Rule 8's that may show intention/be of interest;

Threshold is 1%

Kelso (any increase since last update)

Sparta (confirm media reports)

Apollo (if any position taken?)

List of holders submitting Rule 8 notices

(to save this or nay other thread, switch to 'threaded view' above, save as bookmark)

..bring on the Rule 8's

It's about time we saw who is holding what cards..

Presumably HCM will benefit too with new Shanghai factory ..

https://www.barrons.com/articles/the-fda-is-resuming-drug-lab-inspections-in-china-these-biotechs-could-benefit-76de9cdd?siteid=yhoof2

Decent finish across the pond Friday rather than the usual meltdown, no let up in overseas companies finding a home in China

https://www.scmp.com/business/article/3217232/julius-baer-sets-hong-kong-office-swiss-private-bank-follows-super-rich-clients-eyeing-investment

All looks very investable to me ..

Its going to be an interesting week for sure, expecting Kelso to digest Tuesday's update followed by announcement of their AGM on Wednesday.

They need to put forward some sort of prospectus detailing what they need to funds for, Tuesday's update may well give them the excuse needed.

Using margin a £3m cash injection could be £15m or thereabouts, probably need a bit of spare for possible calls..

..oh to be listed on the London Stock exchange, what a wonderful experience ..

As investors we have to endure our OWN press constantly undermining British industry and jobs, why would anyone want tot list overseas..

750k reported at the days high.

bucking the wider trend (for now) across the pond..

Indeed, bit of a squeeze me thinks, its been a good week for the longs.

Hard to short when everyone is banging China's drum..

Intel chief stresses key microchip role of China

http://www.chinadaily.com.cn/a/202304/13/WS643754eea31057c47ebb9d57.html

https://www.thetimes.co.uk/article/dechra-pharmaceuticals-in-talks-over-possible-4-6bn-bid-from-swedens-eqt-h9rs6lpmv

sorry, that link is not the full write up, here it is :

https://www.balderton.com/news/thg-a-direct-to-consumer-pioneer-born-built-and-thriving-in-manchester-england/